Review
Open access
Sep 2026
Recent Advances in the Antihyperlipidemic Activity of Marine Polysaccharides
Hyperlipidemia is a chronic metabolic disorder in humans, contributing to the onset of cardiovascular diseases (CVDs) that remain the leading cause of death worldwide. Current clinical antihyperlipidemic agents are often accompanied by diverse adverse side effects. Therefore, developing safer novel lipid regulators is...
Yong-Xuan Liu, Hao-Wei Liu, Dan Li et al.
· Marine Drugs · 0 citations